Frontiers in Oncology · 2020 · 45 citations · 30 references
MedicineMolecular GeneticsOncologyGenomicsMolecular OncologyNeoplasiaCancer GenomicsColorectal CancerGermline Cancer PredispositionGermline Cancer SusceptibilityMalignant NeoplasmsMolecular Tumor ProfilingColorectal Cancer PredispositionGenomic Alteration ProfilingGermline MutationsPathogenic Germline VariantsRecurrent Colorectal CancerSomatic Genomic AlterationsTumor Mutation AnalysisTumor Susceptibility Genes
Background Early onset colorectal cancer (EOCRC) is a heterogeneous colorectal cancer subtype with obvious hereditary tendencies and increasing incidence. We sought to determine the susceptibility genes and molecular characteristics of EOCRC. Methods 330 EO metastatic CRC (mCRC) (≤55 years) and 110 average-onset (AO) mCRC patients (>55 years) were enrolled. Capture-based targeted sequencing was performed on tumor tissue and paired white blood cells using a sequencing panel of 520 genes. The association between molecular alterations and overall survival (OS) was analyzed. Results Of the 330 EO mCRC patients, 31 carried pathogenic or likely pathogenic germline mutations, with 16 of them diagnosed with lynch syndrome. Fifteen patients had germline mutations in non-mismatch repair genes, including 4 in MUTHY, 3 in RAD50, 1 in TP53, and 8 in other genes. Twenty-nine genes were recurrently mutated in EO mCRC, including TP53, APC, KRAS, SMAD4, and BRCA2. The majority of genomic alterations were comparable between EO and AO mCRC. EO mCRC were more likely to have a high tumor mutation burden (p < 0.05). RNF43, RBM10, TSC, and BRAF V600E mutations were more commonly observed in EO mCRC, while APC, ASXL1, DNMT3B, and MET genes were more commonly altered in AO patients. At the pathway level, the WNT pathway was the only differentially mutated pathway between EO and AO mCRC (p < 0.0001). The wild-type WNT pathway (p = 0.0017) and mutated TGF-β pathway (p = 0.023) were associated with unfavorable OS in EO mCRC. Conclusions Approximately 1 in 10 EO mCRC were associated with hereditary tumors. The spectrum of somatic alterations was largely comparable between EO and AO mCRC with several notable differences.
30
Comprehensive molecular characterization of human colon and rectal cancer
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold, Mónica S. Sierra, Mathieu Laversanne et al. · Gut · 2016 · 5.3K citations · Full text
The consensus molecular subtypes of colorectal cancer
Justin Guinney, Rodrigo Dienstmann, Xin Wang et al. · Nature Medicine · 2015 · 5.3K citations · Full text
Colorectal cancer statistics, 2017
Rebecca L. Siegel, Kimberly D. Miller, Stacey A. Fedewa et al. · CA A Cancer Journal for Clinicians · 2017 · 3.9K citations · Full text